Blood Adv

Blood Adv

Country: Unknown

Publisher: Unknown

Publication Period: Unknown

920

Papers in Database

Journal Information
Publication Details
Additional Information

Subject Term Count: 1

Last Updated: Aug 05, 2025

Recent Papers

View All 920 Papers
COI Funding
A clinical trial of therapeutic vaccination in lymphoma with serial tumor sampling and single-cell analysis.

Shree T, Haebe S, Czerwinski DK, Eckhert E, Day G, Sathe A, Grimes S, Frank MJ, Maeda LS, Alizadeh …

2024 PMID: 37939259
5/7
Data COI Funding
A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP Registry.

Abou-Ismail MY, Zhang C, Presson AP, Chaturvedi S, Antun AG, Farland AM, Woods R, Metjian A, Park Y…

2024 PMID: 38100454
3/7
COI Funding
Answering the "Doctor, can CAR-T therapy cause cancer?" question in clinic.

Banerjee R, Poh C, Hirayama AV, Gauthier J, Cassaday RD, Shadman M, Cowan AJ, Till BG, Green DJ, Ki…

2024 PMID: 38197942
3/7
COI Funding
A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute lymphoblastic leukemia.

Short NJ, Jabbour E, Jain N, Senapati J, Nasr L, Haddad FG, Li Z, Hsiao YC, Yang JJ, Pemmaraju N, O…

2024 PMID: 38207208
4/7
COI Funding
A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204).

Phillips TJ, Avigdor A, Gurion R, Patti C, Corradini P, Tani M, Mehta A, Lossos IS, Zinzani PL, Thi…

2024 PMID: 38113459
4/7
Data COI Funding
A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AM…

Cai SF, Huang Y, Lance JR, Mao HC, Dunbar AJ, McNulty SN, Druley T, Li Y, Baer MR, Stock W, Kovacso…

2024 PMID: 37871309
4/7
COI Funding
A thrombin-driven neural net diagnoses the antiphospholipid syndrome without the need for interruption of anticoagulati…

de Laat-Kremers RMW, Wahl D, Zuily S, Ninivaggi M, Regnault V, Musial J, de Groot PG, Devreese KMJ,…

2024 PMID: 38163323
2/7
COI
Bendamustine lymphodepletion before axicabtagene ciloleucel is safe and associates with reduced inflammatory cytokines.

Ghilardi G, Paruzzo L, Svoboda J, Chong EA, Shestov AA, Chen L, Cohen IJ, Gabrielli G, Nasta SD, Po…

2024 PMID: 38113468
3/7
COI Funding
Characterizing epigenetic aging in an adult sickle cell disease cohort.

Lê BM, Hatch D, Yang Q, Shah N, Luyster FS, Garrett ME, Tanabe P, Ashley-Koch AE, Knisely MR.

2024 PMID: 37967379
4/7
Data COI Funding